Solstein Capital’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $108K | Hold |
714
| – | – | 0.06% | 148 |
|
|
2025
Q1 | $107K | Hold |
714
| – | – | 0.06% | 125 |
|
|
2024
Q4 | $132K | Hold |
714
| – | – | 0.07% | 119 |
|
|
2024
Q3 | $141K | Hold |
714
| – | – | 0.07% | 118 |
|
|
2024
Q2 | $147K | Hold |
714
| – | – | 0.1% | 109 |
|
|
2024
Q1 | $193K | Hold |
714
| – | – | 0.13% | 92 |
|
|
2023
Q4 | $169K | Hold |
714
| – | – | 0.12% | 97 |
|
|
2023
Q3 | $140K | Hold |
714
| – | – | 0.12% | 101 |
|
|
2023
Q2 | $150K | Buy |
714
+114
| +19% | +$24K | 0.13% | 97 |
|
|
2023
Q1 | $121K | Hold |
600
| – | – | 0.11% | 107 |
|
|
2022
Q4 | $131K | Hold |
600
| – | – | 0.11% | 120 |
|
|
2022
Q3 | $118K | Hold |
600
| – | – | 0.1% | 106 |
|
|
2022
Q2 | $128K | Sell |
600
-200
| -25% | -$42.7K | 0.1% | 121 |
|
|
2022
Q1 | $227K | Hold |
800
| – | – | 0.15% | 104 |
|
|
2021
Q4 | $301K | Hold |
800
| – | – | 0.18% | 108 |
|
|
2021
Q3 | $330K | Buy |
+800
| New | +$330K | 0.19% | 102 |
|